Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02002-5

Dysglycemia and Reperfusion Failure in Patients With ST-Segment Elevation Myocardial Infarction
P. Fink1, M. Reindl1, I. Lechner1, C. Tiller1, M. Holzknecht1, A. Mayr2, M. Theurl1, G. Klug1, C. Brenner1, A. Bauer1, B. Metzler1, S. J. Reinstadler1
1Department für Innere Medizin III - Kardiologie und Angiologie, Medizinische Universität Innsbruck, Innsbruck, AT; 2Radiologie, Medizinische Universität Innsbruck, Innsbruck, AT;

Background:
Failed myocardial tissue reperfusion due to microvascular injury despite successful culprit lesion percutaneous coronary intervention (PCI) is associated with poor clinical outcome in patients with ST-elevation myocardial infarction (STEMI). A possible influence of dysglycaemia on myocardial reperfusion injury is unclear.

Objectives:
To investigate the association between glycaemic status and microvascular injury determined by magnetic resonance imaging in STEMI patients.

Methods:
This prospective observational cohort study included 260 consecutive STEMI patients undergoing primary PCI between 2016 and 2019. Peripheral venous blood samples for glucose and HbA1c measurements were drawn on admission. Primary microvascular injury endpoint was defined as presence of intramyocardial haemorrhage (IMH) assessed by magnetic resonance T2* mapping 4 (interquartile range [IQR]:2-5) days after PCI.

Results:
HbA1c (odds ratio[OR]:1.73 [95%CI:1.24-2.40];p=0.001), pre-diagnosis of diabetes (OR:2.63 [95%CI:1.18-5.90];p=0.02) and glucose concentration (OR:1.01 [95%CI:1.00-1.01];p=0.01) significantly predicted IMH, which was present in 90 (35%) patients. Of these three parameters, only HbA1c remained significantly associated with IMH (OR:2.05 [95% CI:1.09-3.85];p=0.02) after adjusting for total ischemic time, culprit lesion location, pre- and post-interventional TIMI flow and peak biomarker concentrations (troponin, N-terminal pro-B-type natriuretic peptide, C-reactive protein). The rate of IMH was 24% in patients with HbA1c <5.7%, 43% in patients with HbA1c ≥5.7 to 6.4% and 59% in patients with HbA1c ≥6.5 % (p<0.001). After exclusion of patients with diabetes (pre- and newly diagnosed, n=34), HbA1c ≥5.7% remained predictive of IMH in both univariable (OR:2.42 [95% CI:1.36-4.30];p=0.003) and multivariable analysis (OR:3.68 [95% CI:1.64-8.21];p=0.002).

Conclusions:
In STEMI patients undergoing primary PCI, admission HbA1c was independently associated with reperfusion injury as determined by IMH. These findings suggest that IMH could represent the underlying pathophysiological link between dysglycaemia and adverse outcomes following STEMI.

https://dgk.org/kongress_programme/jt2022/aP528.html